With the UK’s default to leave the EU without a deal, there are a number of steps businesses in the life sciences sector should take to prepare. Many companies in the sector are faced with simultaneously navigating an increasingly complex regulatory environment while trying to mitigate as much as possible the significant impact of Brexit – including the effects of weak drug development pipelines, access to talent, supply chain disruption and potentially reduced research and development (R&D) funding.
Only logged in customers who have purchased this product may leave a review.
You may also like
The future of work is at the heart of every major socio-economic-political debate raging around the world today. All of these discussions – be they about walls across borders, migrants landing on the beaches of Southern Europe, surveillance policies in Xinjiang, hard or soft Brexits, taxi services in Paris or the concentration of wealth among the 1% – are rooted in the topic of the nature and distribution of work. From work, and what is derived from it – money –comes power.
21 More Jobs of the Future$0.00 Cognizant
New technologies are fundamentally disrupting the business model for consumer products companies around the world. Relationships between manufacturers and retailers – and the consumers they share – are changing, and new business models are emerging. This is a challenge, certainly, but also a tremendous opportunity.
Achieving Profitable Growth in Consumer Products$0.00 Alix Partner
The financial crisis and its effect on the real economy initiated a debate at the beginning of 2009 on the need to change the financial industry regulation in order to prevent new crises, mitigate systemic risk and develop a balanced framework for competition.
Capital Adequacy for credit risk: A practical exercise$0.00 Management Solutions
Trouble with Conavigo
Want to refine your results?
Help with Sourcing
Need help with your Sourcing?